ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

White House names five to NCAB, reappoints Niederhuber as chairman.

June 25, 2004

AMA Anti-Tobacco, Stop-Smoking Program Uses TV Marketing

April 15, 1994

House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments

August 4, 1995

NIH RFA Available

August 3, 2001

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992